Skip to main content

Table 2 Stem cells products approved for clinic pre-clinic trial by the SFDA

From: Regenerative medicine in China: main progress in different fields

Accept No. Generic name Usage Date Unit Status
X0400586 Bone marrow mesenchymal stem cells Injection 2004.02 The foundation of the Chinese academy of sciences institute of medicine Approved
CSL20020071 Human recombinant stem cell factor for injection Injection 2003.05 The Second Military Medical University Approved
X0408234 Mesenchymal stem cells in myocardial infarction for injection Injection 2005.01 Beijing Yuanhefa Biotechnology Approved
X0407487 Autologous bone marrow mesenchymal stem cells for injection Injection 2004.12 Institute of transfusion medicine, Academy of Military Medical Science of PLA Approved
CSL01037 Recombinant stem cell factor for injection Injection 2001.09 Institute of transfusion medicine, Academy of Military Medical Science of PLA Approved
X0404120 Umbilical cord blood nuclear progenitor cell for injection Injection 2004.07 Institute of transfusion medicine, Academy of Military Medical Science of PLA Approved
X0404119 Umbilical cord blood red blood cell precursors for injection Injection 2004.08 Institute of transfusion medicine, Academy of Military Medical Science of PLA Approved